Jason Douglas Wilson, Chief Financial Officer at REATA PHARMACEUTICALS INC (RETA), sold 6,800 shares at $83.93 ($574K) on 2019-07-15, disclosed to the SEC on 2019-07-17.
Open-market sale of $574k RETA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.93 | 1,811 | $152K | 26.5% |
| 2 | $83.93 | 1,811 | $152K | 26.5% |
| 3 | $84.73 | 989 | $84K | 14.6% |
| 4 | $84.73 | 989 | $84K | 14.6% |
| 5 | $85.64 | 1,200 | $103K | 17.9% |
| Total | $84.46 avg | 6,800 |
| $574K |
| 100% |
| Filing → |
| RETA | SELL | 2019-10-15 | $5.5M | — | Filing → |
| RETA | SELL | 2019-08-16 | $420K | — | Filing → |
| RETA | SELL | 2019-06-19 | $668K | — | Filing → |